News

Chr. Hansen grows 9%

Chr. Hansen saw 9% organic growth in Q1 2014/15 and said that it maintains its full-year expectations of 7-9% organic growth. Revenues were €188 million, up 10% on Q1 2013/14. EBIT before special items was €44 million, compared to €43 million in Q1 2013/14. “With solid organic revenue growth of 9% in Q1 2014/15, Chr. […]

Chr. Hansen saw 9% organic growth in Q1 2014/15 and said that it maintains its full-year expectations of 7-9% organic growth. Revenues were €188 million, up 10% on Q1 2013/14. EBIT before special items was €44 million, compared to €43 million in Q1 2013/14.

“With solid organic revenue growth of 9% in Q1 2014/15, Chr. Hansen has started the year well,” said CEO Cees de Jong. “The Cultures & Enzymes Division (7% organic growth) performed in line with our long-term expectations and the Health & Nutrition Division (29%) delivered very strong growth albeit on weak comparables. The Natural Colors Division (4%) grew below expectation.

The implementation of our Nature’s No. 1 strategy continues. We have accelerated our research & development efforts within biological plant protection and we have strengthened the organization in China to support our new go-to-market strategy for cultures and enzymes. Finally, the implementation of the new dedicated sales and application organization in the Natural Colors Division is on track and we expect the performance of the division to improve during the year.”
“We reiterate our expectations for 2014/15 of organic revenue growth of 7-9% and an EBIT margin before special items above 26.5%.”